$11.24
0.99% yesterday
Nasdaq, Nov 15, 09:50 pm CET
ISIN
US09075A1088
Symbol
BVS

Bioventus Inc - Ordinary Shares - Class A Target price 2024 - Analyst rating & recommendation

Bioventus Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
67%
Sell
33%

Bioventus Inc - Ordinary Shares - Class A Price Target

Target Price $14.67
Price $11.24
Potential
Number of Estimates 3
3 Analysts have issued a price target Bioventus Inc - Ordinary Shares - Class A 2025 . The average Bioventus Inc - Ordinary Shares - Class A target price is $14.67. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 2 Analysts recommend Bioventus Inc - Ordinary Shares - Class A to buy, 0 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Bioventus Inc - Ordinary Shares - Class A stock has an average upside potential 2025 of . Most analysts recommend the Bioventus Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 512.35 564.27
0.04% 10.13%
EBITDA Margin 14.32% 18.71%
31.99% 30.64%
Net Margin -31.75% -3.20%
3.90% 89.92%

3 Analysts have issued a sales forecast Bioventus Inc - Ordinary Shares - Class A 2024 . The average Bioventus Inc - Ordinary Shares - Class A sales estimate is

$564m
Unlock
. This is
1.66% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$565m 1.70%
Unlock
, the lowest is
$564m 1.61%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $512m 0.04%
2024
$564m 10.13%
Unlock
2025
$602m 6.77%
Unlock
2026
$641m 6.33%
Unlock

3 Analysts have issued an Bioventus Inc - Ordinary Shares - Class A EBITDA forecast 2024. The average Bioventus Inc - Ordinary Shares - Class A EBITDA estimate is

$106m
Unlock
. This is
41.37% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$106m 41.96%
Unlock
, the lowest is
$105m 40.86%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $73.4m 32.05%
2024
$106m 43.85%
Unlock
2025
$117m 10.86%
Unlock
2026
$132m 12.89%
Unlock

EBITDA Margin

2023 14.32% 31.99%
2024
18.71% 30.64%
Unlock
2025
19.42% 3.79%
Unlock
2026
20.62% 6.18%
Unlock

3 Bioventus Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2024. The average Bioventus Inc - Ordinary Shares - Class A net profit estimate is

$-18.1m
Unlock
. This is
55.37% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$33.3m 182.25%
Unlock
, the lowest is
$-49.0m 20.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-163m 3.86%
2024
$-18.1m 88.89%
Unlock
2025
$16.6m 191.54%
Unlock
2026
$42.5m 156.62%
Unlock

Net Margin

2023 -31.75% 3.90%
2024
-3.20% 89.92%
Unlock
2025
2.75% 185.94%
Unlock
2026
6.63% 141.09%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -2.49 -0.28
3.86% 88.76%
P/E negative
EV/Sales 1.99

3 Analysts have issued a Bioventus Inc - Ordinary Shares - Class A forecast for earnings per share. The average Bioventus Inc - Ordinary Shares - Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.28
Unlock
. This is
54.84% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.51 182.26%
Unlock
, the lowest is
$-0.75 20.97%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-2.49 3.86%
2024
$-0.28 88.76%
Unlock
2025
$0.25 189.29%
Unlock
2026
$0.65 160.00%
Unlock

P/E ratio

Current -18.21 1,417.50%
2024
-40.63 123.12%
Unlock
2025
44.37 209.21%
Unlock
2026
17.29 61.03%
Unlock

Based on analysts' sales estimates for 2024, the Bioventus Inc - Ordinary Shares - Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.03 56.15%
2024
1.99 1.85%
Unlock
2025
1.87 6.34%
Unlock
2026
1.76 5.95%
Unlock

P/S ratio

Current 1.32 200.29%
2024
1.30 1.63%
Unlock
2025
1.22 6.34%
Unlock
2026
1.15 5.96%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today